Fagron Q1 2026 Revenue Tops Estimates Fagron reported Q1 2026 revenue of €185.6m (+6.8% YoY), beating consensus by ~2.4% on Apr 9, 2026 (Investing.com); margin and cash-flow signs are central to the outlook.

Fagron Q1 2026 Revenue Tops Estimates: Fagron reported Q1 2026 revenue of €185.6m (+6.8% YoY), beating consensus by ~2.4% on Apr 9, 2026 (Investing.com); margin and cash-flow signs are central to the outlook. 👈 Read full analysis #Fagron #RevenueReport #Q12026 #FinancialResults #InvestingNews

Fagron Reports 10.3% Q1 Revenue Growth Fagron reported 10.3% YoY revenue growth for Q1 2026 on Apr 9, 2026; investors will watch margins, cash flow and acquisition integration closely.

Fagron Reports 10.3% Q1 Revenue Growth: Fagron reported 10.3% YoY revenue growth for Q1 2026 on Apr 9, 2026; investors will watch margins, cash flow and acquisition integration closely. 👈 Read full analysis #Fagron #RevenueGrowth #BusinessNews #Investors #FinancialReport

Brazil Recommends Blocking Fagron–Purifarma Merger The General Superintendence of Brazil’s Administrative Council for Economic Defense (SG/CADE) has formally recommended the rejection of the proposed acquisition of Purifarma by SM Empreendimentos, …

🚫 Brazil’s antitrust watchdog recommends blocking Fagron’s takeover of Purifarma. CADE flags 50%+ market share, high entry barriers & risk of price hikes in pharma inputs. Final decision now with the Tribunal.
#Antitrust #Brazil #Fagron #Pharma #CADE
antitrust-intelligence.com/brazil-recom...

Fagron updates on FDA communication regarding the June 2024 inspection at Wichita - Fagron Investors Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 Dec 2024 – 7AM CET Fagron updates on FDA communication regarding the June 2024 inspection at Wichita ...

Updates are supposed to be harmless. This one isn't.
#Fagron shares open 11% lower.
investors.fagron.com/press-releas...

Alleen een magistraal middel kan #Fagron nog redden.

Alleen een magistraal middel kan #Fagron nog redden.